CPT-Pharmacometrics & Systems Pharmacology

Papers
(The H4-Index of CPT-Pharmacometrics & Systems Pharmacology is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Issue Information44
Issue Information42
Issue Information41
Correction to Network module‐based drug repositioning for pulmonary arterial hypertension34
Pharmacometric and statistical considerations for dose optimization30
Association between SARS‐CoV‐2 viral kinetics and clinical score evolution in hospitalized patients28
Issue Information28
Genotype, Ethnicity, and Drug–Drug Interaction Modeling as Means of Verifying Transporter Biomarker PBPK Model: The Coproporphyrin‐I Story27
Easy and reliable maximum a posteriori Bayesian estimation of pharmacokinetic parameters with the open‐source R package mapbayr26
Regulatory utility of physiologically based pharmacokinetic modeling for assessing food impact in bioequivalence studies: A workshop summary report26
A novel integrated QSP model of in vivo human glucose regulation to support the development of a glucagon/GLP‐1 dual agonist26
Designing phase I oncology dose escalation using dose–exposure–toxicity models as a complementary approach to model‐based dose–toxicity models25
Clinical pharmacokinetics of leriglitazone and a translational approach using PBPK modeling to guide the selection of the starting dose in children25
A case‐study of model‐informed drug development of a novel PCSK9 anti sense oligonucleotide. Part 1: First time in man to phase II25
Development of a physiologically based pharmacokinetic model of fostemsavir and its pivotal application to support dosing in pregnancy24
Exposure–response modeling for nausea incidence for cotadutide using a Markov modeling approach24
Physiologically‐based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population23
Evaluation of postprandial total triglycerides within the TIGG model for characterizing postprandial response of glucose, insulin, and GLP‐123
Issue Information23
Evaluation of covariate effects in item response theory models22
A quantitative systems pharmacology approach to support mRNA vaccine development and optimization22
Prediction of a CLDN18.2 Targeted Antibody Drug Conjugate Pharmacokinetics in Cancer Patients Using PBPK Modeling and Simulation21
Pharmacokinetics of Intrapartum Benzylpenicillin: Insights Into Candidate Regimens to Prevent Early Onset Neonatal Group B Streptococcus Disease21
Physiologically‐based pharmacokinetic model of sparsentan to evaluate drug–drug interaction potential21
Increasing application of pediatric physiologically based pharmacokinetic models across academic and industry organizations21
0.19979500770569